A Phase III National Study on One-Year Supervised Physical Activity to Reduce Long-term Fatigue in Men with Metastatic Testicular Germ Cell Tumors
Led by Centre Leon Berard · Updated on 2026-03-31
236
Participants Needed
12
Research Sites
365 weeks
Total Duration
AI-Summary
What This Trial Is About
Metastatic testicular germ cell tumor TGCT is the most common cancer in men aged 15 to 40. Survivors often face lasting effects like chronic fatigue, psychological issues, heart problems, and second cancers despite good survival rates. This research is exploring how a physical activity program may help reduce fatigue and other long-term effects, while also studying how gut bacteria and their byproducts might influence these outcomes in TGCT survivors.
The study is a national, multicenter, phase III randomized controlled trial comparing a one-year supervised physical activity program to usual care with physical activity recommendations and a connected activity tracker. Participants will be randomly assigned to either an intervention group, which includes supervised sessions and motivational interviews, or a control group receiving standard activity guidance and tracking. The physical activity program has two phases during chemotherapy, participants will attend multiple supervised sessions weekly, and after chemotherapy, they will continue regular sessions either online, in fitness centers, or by themselves for up to a year.
Participants will be involved for at least three years, with fatigue as the primary outcome measured at that time. Throughout the study, various assessments including quality of life questionnaires, physical fitness tests, anxiety and depression levels, gut microbiota analysis, and monitoring of treatment side effects will be conducted at multiple time points. Activity adherence will be tracked continuously by the activity trackers, and motivational interviews will support ongoing participation. This trial aims to provide new evidence to improve quality of life and reduce late effects for men with metastatic TGCT.
CONDITIONS
Brief Title
Impact of a Physical Activity Program to Reduce Long-term Cancer-related Fatigue in Metastatic Testicular Germ Cell Tumor Patients
Research Team
C
Carmen Dupuis, PhD
O
Olivia Pérol, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Histologically confirmed metastatic germ cell tumor (seminoma or non-seminoma)
Planned first-line chemotherapy with BEP, EP, or VIP
Ownership of a smartphone to connect the activity tracker
Performance status of 2 or less
Medical certificate confirming ability to perform adapted physical activity
Willing and available to participate for the full study and follow-up
Able to read, write, and understand French
Affiliated with a social security scheme
Signed informed consent form
You will not qualify if you...
Symptomatic bone and/or brain metastases
Central nervous system issues causing neurological deficits that prevent walking
History or presence of another primary cancer except certain skin cancers or cancers in remission for over 3 years
Contraindications to physical activity such as uncontrolled hypertension or heart disease
Inability to be followed medically or socially for the entire study
Legal restrictions such as deprivation of liberty or legal protection
Participation in another physical activity study concurrently
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Physical Activity Intervention
Duration - 1 year
Participants follow a supervised physical activity program lasting 1 year, which includes 2-4 sessions per week during chemotherapy cycles and 1-2 supervised online sessions per week between cycles. After chemotherapy, participants perform 2-3 physical activity sessions per week through supervised online sessions, fitness center access, or self-practice, along with 4 individual motivational interviews by videoconference or phone.
Regular sessions scheduled weekly, plus 4 individual motivational interviews
Long-term Monitoring
Duration - Up to 10 years
Participants are monitored for fatigue, quality of life, physical condition, and other health outcomes up to 10 years after starting chemotherapy to assess long-term effects of the intervention.
Visits at inclusion, end of chemotherapy (Month 4), Month 6, Month 12, and annually up to Year 10
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
A Phase III National Study on One-Year Supervised Physical Activity to Reduce Long-term Fatigue in Men with Metastatic Testicular Germ Cell Tumors
At-Home Taste Steering to Improve Food Enjoyment in Adults Undergoing Chemotherapy for Specific Cancers
A Multicentre Randomized Trial in the Netherlands
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Impact of a one-year supervised physical activity program on long-term cancer-related fatigue and mediating effects of the gut microbiota in metastatic testicular cancer patients: protocol of the prospective multicentre, randomized controlled phase-III STARTER trial.